190 related articles for article (PubMed ID: 37984761)
21. In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome.
Todt D; Gisa A; Radonic A; Nitsche A; Behrendt P; Suneetha PV; Pischke S; Bremer B; Brown RJ; Manns MP; Cornberg M; Bock CT; Steinmann E; Wedemeyer H
Gut; 2016 Oct; 65(10):1733-43. PubMed ID: 27222534
[TBL] [Abstract][Full Text] [Related]
22. Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study.
Kamar N; Abravanel F; Behrendt P; Hofmann J; Pageaux GP; Barbet C; Moal V; Couzi L; Horvatits T; De Man RA; Cassuto E; Elsharkawy AM; Riezebos-Brilman A; Scemla A; Hillaire S; Donnelly MC; Radenne S; Sayegh J; Garrouste C; Dumortier J; Glowaki F; Matignon M; Coilly A; Figueres L; Mousson C; Minello A; Dharancy S; Rerolle JP; Lebray P; Etienne I; Perrin P; Choi M; Marion O; Izopet J;
Clin Infect Dis; 2020 Aug; 71(5):1204-1211. PubMed ID: 31793638
[TBL] [Abstract][Full Text] [Related]
23. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin.
Lhomme S; DebRoy S; Kamar N; Abravanel F; Metsu D; Marion O; Dimeglio C; Cotler SJ; Izopet J; Dahari H
Viruses; 2019 Jul; 11(7):. PubMed ID: 31323954
[TBL] [Abstract][Full Text] [Related]
24. Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective.
Todesco E; Mazzola A; Akhavan S; Abravanel F; Poynard T; Roque-Afonso AM; Peytavin G; Marcelin AG; Calmus Y; Lecuyer L; Guillemain R; Conti F
Antivir Ther; 2018; 23(5):463-465. PubMed ID: 29504509
[TBL] [Abstract][Full Text] [Related]
25. Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study.
Péron JM; Abravanel F; Guillaume M; Gérolami R; Nana J; Anty R; Pariente A; Renou C; Bureau C; Robic MA; Alric L; Vinel JP; Izopet J; Kamar N
Liver Int; 2016 Mar; 36(3):328-33. PubMed ID: 26179015
[TBL] [Abstract][Full Text] [Related]
26. The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo.
Todt D; Moeller N; Praditya D; Kinast V; Friesland M; Engelmann M; Verhoye L; Sayed IM; Behrendt P; Dao Thi VL; Meuleman P; Steinmann E
Antiviral Res; 2018 Sep; 157():151-158. PubMed ID: 30036559
[TBL] [Abstract][Full Text] [Related]
27. Modelling of Hepatitis E virus RNA-dependent RNA polymerase genotype 3 from a chronic patient and
Cancela F; Rendon-Marin S; Quintero-Gil C; Houston DR; Gumbis G; Panzera Y; Pérez R; Arbiza J; Mirazo S
J Biomol Struct Dyn; 2023 Feb; 41(2):705-721. PubMed ID: 34861797
[TBL] [Abstract][Full Text] [Related]
28. Mutagenic Effects of Ribavirin on Hepatitis E Virus-Viral Extinction versus Selection of Fitness-Enhancing Mutations.
Todt D; Walter S; Brown RJ; Steinmann E
Viruses; 2016 Oct; 8(10):. PubMed ID: 27754363
[TBL] [Abstract][Full Text] [Related]
29. The macrolide antibiotic azithromycin potently inhibits hepatitis E virus in cell culture models.
Miao Z; Zhang R; Yu P; Li Y; Pan Q; Li Y
Int J Antimicrob Agents; 2021 Sep; 58(3):106383. PubMed ID: 34157403
[TBL] [Abstract][Full Text] [Related]
30. Targeting proteostasis of the HEV replicase to combat infection in preclinical models.
Zhang F; Xu LD; Zhang Q; Wang A; Yu X; Liu S; Chen C; Wu S; Jin J; Lin A; Neculai D; Zhao B; Feng XH; Liang T; Xu P; Huang YW
J Hepatol; 2023 Apr; 78(4):704-716. PubMed ID: 36574921
[TBL] [Abstract][Full Text] [Related]
31. The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study.
von Felden J; Alric L; Pischke S; Aitken C; Schlabe S; Spengler U; Giordani MT; Schnitzler P; Bettinger D; Thimme R; Xhaard A; Binder M; Ayuk F; Lohse AW; Cornelissen JJ; de Man RA; Mallet V
J Hepatol; 2019 Sep; 71(3):465-472. PubMed ID: 31108159
[TBL] [Abstract][Full Text] [Related]
32. The Clinical Perspective on Hepatitis E.
Horvatits T; Schulze Zur Wiesch J; Lütgehetmann M; Lohse AW; Pischke S
Viruses; 2019 Jul; 11(7):. PubMed ID: 31284447
[TBL] [Abstract][Full Text] [Related]
33. Dosing ribavirin in hepatitis E-infected solid organ transplant recipients.
De Winter BCM; Hesselink DA; Kamar N
Pharmacol Res; 2018 Apr; 130():308-315. PubMed ID: 29499270
[TBL] [Abstract][Full Text] [Related]
34. Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report.
Goyal R; Kumar A; Panda SK; Paul SB; Acharya SK
Antivir Ther; 2012; 17(6):1091-6. PubMed ID: 22910532
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis E Virus Infection in Lung Transplant Recipients: A Case Series.
Ambrocio GPL; Aguado S; Carrillo J; Laporta R; Lazaro-Carrasco M; Avellon A; Aran-Toha G; Ussetti M; Aguilar M
Transplant Proc; 2019 Mar; 51(2):376-379. PubMed ID: 30879545
[TBL] [Abstract][Full Text] [Related]
36. Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience.
Pischke S; Hardtke S; Bode U; Birkner S; Chatzikyrkou C; Kauffmann W; Bara CL; Gottlieb J; Wenzel J; Manns MP; Wedemeyer H
Liver Int; 2013 May; 33(5):722-6. PubMed ID: 23489973
[TBL] [Abstract][Full Text] [Related]
37. Protracted fecal shedding of HEV during ribavirin therapy predicts treatment relapse.
Abravanel F; Lhomme S; Rostaing L; Kamar N; Izopet J
Clin Infect Dis; 2015 Jan; 60(1):96-9. PubMed ID: 25249523
[TBL] [Abstract][Full Text] [Related]
38. Relevance of chronic hepatitis E in liver transplant recipients: a real-life setting.
Galante A; Pischke S; Polywka S; Luetgehethmann M; Suneetha PV; Gisa A; Hiller J; Dienes HP; Nashan B; Lohse AW; Sterneck M
Transpl Infect Dis; 2015 Aug; 17(4):617-22. PubMed ID: 26094550
[TBL] [Abstract][Full Text] [Related]
39. Recapitulating hepatitis E virus-host interactions and facilitating antiviral drug discovery in human liver-derived organoids.
Li P; Li Y; Wang Y; Liu J; Lavrijsen M; Li Y; Zhang R; Verstegen MMA; Wang Y; Li TC; Ma Z; Kainov DE; Bruno MJ; de Man RA; van der Laan LJW; Peppelenbosch MP; Pan Q
Sci Adv; 2022 Jan; 8(3):eabj5908. PubMed ID: 35044825
[TBL] [Abstract][Full Text] [Related]
40. Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver.
Sayed IM; Verhoye L; Cocquerel L; Abravanel F; Foquet L; Montpellier C; Debing Y; Farhoudi A; Wychowski C; Dubuisson J; Leroux-Roels G; Neyts J; Izopet J; Michiels T; Meuleman P
Gut; 2017 May; 66(5):920-929. PubMed ID: 27006186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
